Weekend reads: An alternative to the impact factor in China; the clinical trials of six ‘superretractors’; Retraction Watch goes to Capitol Hill
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Retraction Watch reportedly testified in a Congressional hearing on scientific publishing. The topic of the hearing and the content of the testimony are not specified, but it may be related to issues such as scientific fraud, journal editing, or the reliability of research. Other reports suggest that Retraction Watch has also been covering various topics related to scientific publishing, including data falsification and editorial controversies.
Full coverage
1234567